SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-082225
Filing Date
2024-07-09
Accepted
2024-07-08 19:12:05
Documents
14
Period of Report
2024-06-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cvsi-20240703.htm   iXBRL 8-K 46944
2 EX-10.1 cvsi-ex10_1.htm EX-10.1 188553
3 EX-10.2 cvsi-ex10_2.htm EX-10.2 65570
4 EX-10.3 cvsi-ex10_3.htm EX-10.3 91334
  Complete submission text file 0000950170-24-082225.txt   557498

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cvsi-20240703.xsd EX-101.SCH 22160
17 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20240703_htm.xml XML 4003
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54677 | Film No.: 241106085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)